GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 787.00
+67.00 (9.31%)
Last updated: Apr 16, 2026, 2:23 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 65.28 billion as of April 15, 2026. Its market cap has decreased by -60.87% in one year.
Market Cap
65.28B
Enterprise Value
96.51B
Revenue
23.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
787.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 65.28B, an increase of 1,820.14%. That is a compound annual growth rate of 10.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 65.28B | -60.89% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 180.63B |
| Vaxcell-Bio Therapeutics | 179.55B |
| Macrogen | 177.58B |
| ENCell | 159.15B |
| Amicogen | 139.50B |
| iNtRON Biotechnology | 116.66B |
| CG Invites | 103.73B |
| Oncocross | 94.52B |